Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klemens Budde
Bruce Kaplan

Showing results (1-10 of 735) with videos related to

Pageof 74
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2023
Stronger together: Lessons from the iBox qualification processKlemens Budde, Bruce Kaplan
Transplant International : Official Journal of the European Society for Organ Transplantation|May 3, 2024
How to Treat T Cell Mediated Rejection? -A Call for ActionKlemens Budde
Kidney International|September 22, 2023
A first small step toward personalized immunosuppressionKlemens Budde, Lionel Rostaing
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2019
Risks and benefits of everolimusKlemens Budde, Fabian Halleck
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 2, 2011
Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibitionKlemens Budde, Jens Gaedeke
Journal of the American Society of Nephrology : JASN|January 27, 2018
Any Progress in the Treatment of Antibody-Mediated Rejection?Klemens Budde, Michael Dürr
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Proposal for guidelines for publication of randomized trials in the American Journal of TransplantationKlemens Budde, Lutz Fritsche
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Lancet (London, England)|January 28, 2023
Six pills less: no benefit for bicarbonate supplementation in renal allograft recipientsKlemens Budde, Fabian Halleck
Pageof 74

Showing results (1-10 of 735) with videos related to

Sort By:
Pageof 74
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2023
Stronger together: Lessons from the iBox qualification processKlemens Budde, Bruce Kaplan
Transplant International : Official Journal of the European Society for Organ Transplantation|May 3, 2024
How to Treat T Cell Mediated Rejection? -A Call for ActionKlemens Budde
Kidney International|September 22, 2023
A first small step toward personalized immunosuppressionKlemens Budde, Lionel Rostaing
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2019
Risks and benefits of everolimusKlemens Budde, Fabian Halleck
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 2, 2011
Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibitionKlemens Budde, Jens Gaedeke
Journal of the American Society of Nephrology : JASN|January 27, 2018
Any Progress in the Treatment of Antibody-Mediated Rejection?Klemens Budde, Michael Dürr
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Proposal for guidelines for publication of randomized trials in the American Journal of TransplantationKlemens Budde, Lutz Fritsche
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Lancet (London, England)|January 28, 2023
Six pills less: no benefit for bicarbonate supplementation in renal allograft recipientsKlemens Budde, Fabian Halleck
Pageof 74